Moolec Science (MLEC) Free Cash Flow (2022 - 2024)
Moolec Science's (MLEC) quarterly Free Cash Flow came in at $1.9 million in Q4 2024, down 13.22% year-on-year from $2.2 million in Q1 2024, and up 280.89% quarter-over-quarter from -$1.1 million in Q3 2024.
Moolec Science (MLEC) Free Cash Flow (2022 - 2024) Analysis & Trends
Moolec Science has disclosed Free Cash Flow across 3 years of filings, most recently posting $1.9 million for Q4 2024.
- Free Cash Flow for Q4 2024 came in at $1.9 million, down 13.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (changed N/A YoY), and the FY2025 annual result was -$2.0 million, down 106.8% from the prior year.
- Free Cash Flow came in at $1.9 million for Q4 2024 at Moolec Science, up from -$1.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $37.8 million in Q2 2024 to a low of -$47.8 million in Q2 2023.
- The 3-year median for Free Cash Flow is -$600786.5 (2022), against an average of -$1.4 million.
- Peak annual rise in Free Cash Flow reached 475.06% in 2023, while the deepest fall reached 17089.24% in 2023.
- Moolec Science's Free Cash Flow stood at -$592663.0 in 2022, then soared by 475.06% to $2.2 million in 2023, then dropped by 13.22% to $1.9 million in 2024.
- The last three Free Cash Flow figures came in at $1.9 million (Q4 2024), -$1.1 million (Q3 2024), and $37.8 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Sep 30, 2024 | -1.07 Mn |
| Jun 30, 2024 | 37.78 Mn |
| Jun 30, 2024 | 37.78 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Mar 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Sep 30, 2023 | -1.64 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Jun 30, 2023 | -47.81 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Mar 31, 2023 | -4.26 Mn |
| Dec 31, 2022 | -592,663.00 |
| Dec 31, 2022 | -592,663.00 |
| Sep 30, 2022 | 9,648.00 |
| Sep 30, 2022 | 9,648.00 |